WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Emerging Market Strategies - Mapping the Opportunities for Pharmaceutical Expansion

CBR Pharma Insights, April 2010, Pages: 54

With a variety of factors impacting pharmaceutical growth in the traditional markets (the US, 5EU and Japan) – price controls, moves towards generics, healthcare reform, market saturation – the emerging markets (EMs) hold increasing potential to drive future product sales and overall company revenues.

The different situations which exist within each emerging market offer a wide variety of opportunities along with their own set of accompanying challenges. In order to best break in and position themselves within the various emerging markets, pharmaceutical companies are employing several different strategies. These strategies include: sales force growth, tiered pricing, generics, acquisitions/partnerships and an urban vs. rural focus.

The Emerging Markets Strategies report assesses why companies are looking outside of the traditional markets for company growth, the overall potential within the EMs, and the various strategies that are used to accomplish their long term goals. Additionally, CBR Pharma Insights looks at the opportunities and challenges which exist in the major, and the up & coming, emerging markets.

Reasons to Purchase

- Use this report to identify the key entry strategies that are most appropriate for the different emerging markets

- Navigate the potential pitfalls that exist within the major emerging markets

- Pinpoint which of the newer emerging markets might be the most appropriate for your organization to target and which hold the potential for long term growth

- Compare and assess the efforts of other pharmaceutical companies in their expansion into new markets

- Understand the factors that are driving pharmaceutical companies to explore emerging markets

- Utilize extremely user-friendly, insight driven content to support key projects, presentations, and decisions within your organization

Executive Summary

Why the Drive to Emerging Markets?
- Factors Slowing Growth in Traditional Markets
- The Potential in Emerging Markets

Strategies for Expansion in the Emerging Markets
- Sales Force Growth
- Tiered Pricing
- Generics
- Partnerships/Acquisitions
- Urban v Rural Focus

Potential and Pitfalls in the Major Emerging Markets
- Brazil
- China
- India
- Russia
- Turkey

Outlook for the Emerging Markets – Where to Next?
- Argentina
- Mexico
- Poland
- Saudi Arabia
- South Africa
- South Korea

Appendix

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought